Hayri Özsan

480 citations
21 papers · 308 indexed · h-index 8
Topics
Multiple Myeloma Research and Treatments (4 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers)Pregnancy and preeclampsia studies (2 papers)
Journals
SHILAP Revista de lepidopterologíaBloodJournal of Thrombosis and Haemostasis

In The Last Decade

Hayri Özsan

20 papers receiving 298 citations

Peers

Hayri Özsan
Comparison fields: 5 of 50
  • Physiology 127
  • Hematology 118
  • Molecular Biology 86
  • Cell Biology 63
  • Epidemiology 60
Replace Karl C. Desch with:
Karl C. Desch United States
Ruoqi Peng United States
R. Zigelman Israel
Mélanie Néel France
Shaoyan Hu China
Ww Bakker Netherlands
Sara Mach‐Pascual Switzerland
Maria De Bonis Italy
Ria C. Boertjes Netherlands
Klaus-Peter Radtke United States
Hayri Özsan relative to Karl C. Desch United States Karl C. Desch's profile →
Citations per field
00.5×4.6×
Karl C. Desch · 1×
Citations per year

Countries citing papers authored by Hayri Özsan

Since Specialization
Citations

This map shows the geographic impact of Hayri Özsan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hayri Özsan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hayri Özsan more than expected).

Fields of papers citing papers by Hayri Özsan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hayri Özsan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hayri Özsan. The network helps show where Hayri Özsan may publish in the future.

Co-authorship network of co-authors of Hayri Özsan

This figure shows the co-authorship network connecting the top 25 collaborators of Hayri Özsan. A scholar is included among the top collaborators of Hayri Özsan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hayri Özsan. Hayri Özsan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 55
2 3
3 3
4 13
5 6
6 5
7
Pesg PNH diagnosis, follow-up and treatment guidelines.
29
8 3
9 1
10 1
11 3
12 122
13 0
14 10
15 1
16 16
17
Primary stenting in a patient with acute myocardial infarction and primary antiphospholipid syndrome.
9
18
Alanine aminotransferase deficiency in a hepatitis B surface antigen positive patient presenting with acute hepatitis.
1
19 2
20 18

About Hayri Özsan

Hayri Özsan is a scholar working on Hematology, Genetics and Obstetrics and Gynecology, having authored 21 papers that have together received 308 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Pregnancy and preeclampsia studies (2 papers). The work is most often cited by research in Hematology (118 citations), Physiology (127 citations) and Genetics (50 citations). Hayri Özsan has collaborated with scholars based in Türkiye, Spain and United States. Frequent co-authors include Zachary Spigelman, Maria Domenica Cappellini, Jesús Villarrubia, María Helena Solano, Elena Lukina, Pramod K. Mistry, Nora Watman, Gero Massenkeil, Hanna Rosenbaum and Mehmet Ali Özcan. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and Journal of Thrombosis and Haemostasis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026